Want to join the conversation?
Jason Mills of Canaccord asks about the market dynamics with respect to AngioVac. $ANGO CEO Jim Clemmer replied that there is not really a competitive offering from a product standpoint that can do what this product does. He added that the challenge for the company is just making sure it is going to market in a proper way.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.